The failure to induce self-tolerance of simian virus 40 large tumor antigen (T antigen) expressed in the pancreatic (3 cells of transgenic mice results in an autoimmune response against this protein and the cells that synthesize it. In every transgenic mouse with delayed onset of T-antigen expression and consequent nontolerance, B cells, T cells, and macrophages are attracted to and infiltrate the pancreatic islets. In contrast, the incidence, onset, and intensity of the B-cell response to produce anti-T-antigen autoantibodies vary considerably with genetic background. Thus the initial attraction of lymphocytes to the cells synthesizing a non-self antigen can be separated from the activation of a B-cell response against it.
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Haplotypes of the major histocompatibility complex (MHC) differentially influence the character of the autoimmune response, with H-2d and H-2k conferring a high incidence of humoral autoimmunity. Additional non-MHC linked genes are also implicated in control of the B-cell response.
It is well established that the immune system develops a capacity to discriminate between foreign and self entities (1) . The importance of tolerance toward self can be seen in a number of diseases of apparent autoimmune nature, in which tissues are selectively destroyed by the immune system (2) . Common features to many autoimmune diseases are the development of circulating autoantibodies that are reactive to components of the tissue undergoing destruction (3) and the correlation of the autoimmune phenotype with specific haplotypes of the major histocompatibility complex (MHC) (4) (5) (6) .
Recently, transgenic mice have been used in a number of experiments designed to test theories of self-tolerance or autoimmunity (7) . We have developed one such transgenic model, which has allowed aspects ofthe relationship between self-tolerance and autoimmunity to be examined (8-10). The rat insulin gene regulatory region was used to selectively express the large tumor antigen (T antigen, or Tag) of simian virus 40 (SV40) in the insulin-producing A3 cells of the pancreatic islets in several lines of transgenic mice (RIP-Tag mice). Every transgenic individual eventually succumbs to pancreatic /3-cell tumors. Besides this commonality, the lineages can be subdivided into two classes. In the first class, mice begin to express the hybrid gene during embryogenesis (developmental onset). In contrast, in several other lines, the insulin/T-antigen gene is first activated in a heterogeneous subset of the p cells beginning at 10-12 weeks after birth (delayed onset). The immune system responds in two different ways to the two distinct patterns of expression among these lineages (9) . Mice with developmental onset of expression are nonresponsive (or self-tolerant) to this new self protein. In contrast, mice in the lines with delayed onset of expression are fully responsive upon immunization with purified large T protein. This nontolerance to a new A-cell antigen is associated with the development of a spontaneous autoimmune response against T antigen and the cells that synthesize it, as evidenced by the appearance of circulating antibodies against the protein and cellular infiltration of the pancreatic islets. It is of note that the insulinomas that develop in these mice manage to escape this autoimmune response and, as a result, the mice become hyperinsulinemic and do not evidence frank diabetes. Here we examine the time course of the autoimmune response, as evidenced by the appearance of autoantibodies, a property that can be monitored noninvasively over time, and assess the possibility that genetic factors, including the MHC, contribute to the induction of autoimmunity.
MATERIALS AND METHODS
Mice. The inbred strains C57BL/6, C57BL/10, DBA/2, and C3HeB/Fe, the congenic strains B1O.BR and B1O.D2, and the hybrid C57BL/6 x DBA/2 F1 mice (B6D2F1) were purchased from The Jackson Laboratory. The RIP1-Tag3 line of transgenic mice has been described (8).
Determination of H-2 Haplotype. Restriction fragment length polymorphisms for BstEII and Pvu II at the Ap locus of the H-2b and H-2d haplotypes, visualized by hybridization to A cDNA probe, were used to determined H-2 composition of transgenic mice (11, 12) . Immunohistochemistry. T antigen was detected as described (9) . Lymphocyte typing was performed on adjacent cryostat sections with rat monoclonal antibodies (mAbs) directed against the Lyt2 (clone 53.6.7), L3T4 (clone GK1.5), B220 (clone 6B2), and Macl (clone M170) surface determinants of the cytotoxic T cells, helper T cells, B cells, and macrophages, respectively, using the alkaline phosphatase system (ABC-AP kit, Vector Laboratories).
Quantitation of Anti-T-Antigen Autoantibodies. Blood samples were collected from the orbital plexus of transgenic or appropriate control mice. Solid-phase radioimmunoassays (RIA) were performed in Dynatech 96-well microtiter plates coated with purified SV40 T protein (13, 14) . Plates were blocked with 1% bovine serum albumin and serial dilutions of test and control sera were absorbed onto coated plates.
Bound antibody was allowed to react with 1251-labeled rabbit anti-mouse IgG antibody (Amersham), and individual wells were cut out and assayed for radioactivity in a 1272 Clingamma counter (LKB). The titer is defined as the dilution of a test serum that results in 50% of the maximum signal obtained with mAb 416 (14) , an anti-Tag mouse mAb used as a positive control. (9) . It is conceivable that the incomplete penetrance results from genetic differences. The founders of these transgenic lines were constructed in F2 hybrids between C57BL/6 and DBA/ 2 inbred mice, and for the first few generations (six) the lines were propagated by brother/sister intercrosses and also by backcrosses to C57BL/6 and B6D2F1 mice (8). Therefore, we first tested whether the C57BL/6 and DBA/2 genetic backgrounds could differentially affect the B-cell response in the RIP1-Tag3 line. Randomly selected RIP1-Tag3 males were mated with females of either the C57BL/6 or DBA/2 parental strains, and the development of serum antibodies reacting with SV40 T antigen in the transgenic progeny was monitored in samples collected periodically over a period of 30 weeks. Virtually all of the transgenic progeny derived from the DBA/2 cross developed high levels of serum anti-Tag antibodies by 20-25 weeks of age. In contrast, a smaller fraction (ca. 30%) oftransgenic animals originating from the C57BL/6 cross developed humoral responses against Tag (Fig. 1 ).
Association of Autoimmunity with MHC Haplotype. Subsequent experiments sought to characterize the DBA/2 locus (or loci) that stimulates the autoantibody response in RIP1-Tag3 mice. One candidate is the MHC. The H-2 haplotypes of a number of RIP1-Tag3 mice were determined, and brothers and sisters homozygous for the H-2 b allele were used to derive an H-2 b/b subline (RIP1-Tag3B), which has been maintained by continuous backcrossing to C57BL/6. RIP1-Tag3B males were mated to B6D2F1 (H-2 bid) hybrid females, and the activation of the B-cell response in their transgenic progeny was monitored periodically as before. Twenty of 27 mice (74%) developed autoantibodies by 30 weeks of age ( Fig. 1) . To test whether a specific MHC haplotype was being (weeks) cosegregated with the autoimmune phenotype, the MHC haplotypes of a subset ofthe transgenic progeny derived from this cross were determined. Interestingly, among the H-2b/b offspring only 38% (5 of 13) had autoantibodies by 30 weeks of age. In contrast, a significantly higher incidence of autoantibodies was observed in mice carrying H-2b and H-2d haplotypes, where 75% (9 of 12 mice) evidenced serum antibodies reacting with T antigen at 30 weeks (Fig. 2) . The B-Cell Response Is Influenced by the MHC and a Second Locus. To further characterize the apparent association of the MHC haplotype with the incidence of B-cell autoimmunity, additional combinations of haplotypes were constructed by crossing RIP1-Tag3B mice with different histocompatibility congenic strains and with distinct inbred strains. RIP1-Tag3B males were crossed to C57BL/10 (H_2b), to the congenic strains B10.D2 (H-2d) and B10.BR (H-2k), and also to DBA/2 (H-2d) and C3HeB (H-2k). The incidence of autoantibodies in the transgenic progeny from these outcrosses was assessed, and the data are summarized in Table 1 . When the H-2 b/b transgenics derived from crosses to C57BL/6 or C57BL/10 are compared to the H-2 bld or H-2b/k offspring derived from crosses to C57BL/10 congenic strains, it can be seen that the d and the k haplotypes confer a higher incidence of autoantibodies ('16% for b/b compared to -56% for bid and b/k). These results confirm the differential effects of MHC alleles on the activation of the B-cell response. However, the same haplotype combinations conferred a 100% incidence of autoimmunity when constructed by crossing RIP1-Tag3B mice to either DBA/2 or C3HeB. If one assumes identity of MHC haplotypes between B1O.BR and C3HeB (which differ at the Tla and Qa-J loci), this observation implies that a second non-MHC locus contributes to the control of the B-cell response. This conclusion is consistent with the results obtained with the B6D2F1 cross, where the H_2b and H_2d alleles are reassorting along with the other chromosomes from the C57BL and DBA/2 backgrounds. In this cross 67% of the H_2bld progeny evidenced autoantibodies at a comparable age (25 weeks), which is significantly lower than the 100o incidence in the DBA/2 and C3HeB crosses. Thus the incidence of B-cell activation to produce anti-T-antigen autoantibodies in these transgenic mice is influenced by at least .g., Fig. 3 ). Taken together these observations indicate that homing of leukocytes to the site of a perceived abnormality can be separated from the activation of those immune cells to destroy the cells that have attracted their attention.
MHC Association with B-Cell Activation. The B-lymphocyte response toward the transgenic 13-cell protein ensues at high frequency when the delayed onset of expression of the transgene is combined with the H-2d or H-2k haplotypes of the major histocompatibility complex. In contrast, RIP1-Tag3 mice homozygous for the H-2b haplotype develop a humoral response much less frequently. Furthermore, the intensity of the B-cell response is markedly weaker in the H-2 b/b mice, as seen in the serum autoantibody titers, which are characteristically 100-fold lower than those arising in transgenic mice with H_2bld or H_2b/k haplotype. These results might suggest an involvement of the I-E region, since the H-2b MHC encodes a defective Ea gene (15, 16) and, as a result, H-2 b/b mice do not express a functional I-E heterodimer on the cell surface (16) . However, if I-E is involved, its absence does not completely abrogatepresentation of Tag peptides by class II, since -16% of H-2 b/b RIP1-Tag3 mice eventually develop anti-Tag autoantibodies (Table 1 ).
An Additional Locus Influences the B-Cell Autoimmune Response. Although a major component of the genetic control of the B-cell autoimmune response against T antigen is linked to the MHC, there were statistically significant differences in the incidence of autoantibodies among transgenic mice with the same MHC haplotypes (either H-2b/d or H-2b/ but differing in strain background (Table 1 ). In addition, it is remarkable that only a small fraction (-16%) of the H_2b/b mice eventually develop a B-cell response against T antigen, despite the development of pancreatic P-cell tumors expressing this nontolerant antigen. These observations together resulted in the establishment of self-tolerance in some cases, but not in others, as assessed by different in vitro assays. However, regardless of their tolerance status, there is a consistent feature in these models: in all cases, the presence of a non-self MHC molecule did not trigger an autoimmune response against the tissue where it was expressed. Thus the model described here is clearly different, since the delayed expression of a non-MHC antigen, large T antigen, results in nontolerance and induces leukocyte infiltration ofthe islets of Langerhans in every RIP1-Tag3 mouse. In two other transgenic models, expression of interferon y (IFN-'y) (29) or influenza virus hemagglutinin (HA) (30) in the pancreatic (3 cells also resulted in autoimmune responses that were concomitant with or preceded by abnormalities in the pancreatic /3 cells themselves. One interpretation of the dichotomy between the effects of MHC molecules, on the one hand, and T antigen/IFN-y/HA, on the other, is that both nontolerance and other as yet undefined abnormal conditions are necessary for the induction of an autoimmune response. In this regard, it is notable that various abnormalities result from expressing the large T protein in / cells; these include increased /B-cell senescence, extensive /3-cell proliferation, and neovascularization (31, 32) . Perhaps one or another of these abnormal conditions is necessary in addition to the immunogenic properties of a nontolerant self antigen to induce leukocyte infiltration of the islets and their subsequent functional activation to produce autoantibodies.
